# Investigator Initiated Study - Asenapine Early Psychosis

> **NCT01968161** · PHASE4 · UNKNOWN · sponsor: **Centre de Recherche de l'Institut Universitaire en Santé Mentale de Québec** · enrollment: 12 (estimated)

## Conditions studied

- Schizophrenia and Disorders With Psychotic Features
- Disorders

## Interventions

- **DRUG:** Asenapine

## Key facts

- **NCT ID:** NCT01968161
- **Lead sponsor:** Centre de Recherche de l'Institut Universitaire en Santé Mentale de Québec
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-10
- **Primary completion:** 2014-02
- **Final completion:** 2014-03
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2014-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01968161

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01968161, "Investigator Initiated Study - Asenapine Early Psychosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01968161. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*